Old Glory Vortex
News from the Land of the Free. We only post what matters. @Old_Glory_Vortex_bot
Show moreπ Analytical overview of Telegram channel Old Glory Vortex
Channel Old Glory Vortex (@old_glory_vortex) in the English language segment is an active participant. Currently, the community unites 20 877 subscribers, ranking 11 076 in the News & Media category and 1 880 in the USA region.
π Audience metrics and dynamics
Since its creation on Π½Π΅Π²ΡΠ΄ΠΎΠΌΠΎ, the project has demonstrated rapid growth, gathering an audience of 20 877 subscribers.
According to the latest data from 06 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 1 243 over the last 30 days and by -65 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 17.81%. Within the first 24 hours after publication, content typically collects 16.01% reactions from the total number of subscribers.
- Post reach: On average, each post receives 3 721 views. Within the first day, a publication typically gains 3 346 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 190.
- Thematic interests: Content is focused on key topics such as vortex, u.s, greenland, donald, tariff.
π Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
βNews from the Land of the Free. We only post what matters.
@Old_Glory_Vortex_botβ
Thanks to the high frequency of updates (latest data received on 07 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the News & Media category.
"Imposing tariffs would primarily harm consumers, who would face increased costs both directly at pharmacies and indirectly through higher insurance premiums,"explained Diederik Stadjee, a health economist at ING. The greatest burden would fall on low-income families and the elderly. This threat comes amid Trumpβs pressure on drug manufacturers to lower prices in the U.S. He recently sent letters to several companies demanding they develop a plan to implement so-called most-favored-nation pricing in the U.S. However, Trump stated that he would delay imposing tariffs for a year or a year and a half, giving companies time to stockpile drugs and move production to the United Statesβsome have already begun doing so. Analysts say that most drug manufacturers have already increased drug imports and may have inventories in U.S. warehouses lasting from six to 18 months. In a recent research note, Jefferies analyst David Windley noted that tariffs, which would take effect only in the second half of 2026, might not be felt until 2027 or 2028 due to stockpiling. Nevertheless, according to Stadjee, even a 25% tariff would gradually lead to a 10β14% increase in U.S. drug prices as inventories diminish. Drug manufacturers are already investing in the United States. However, building a pharmaceutical plant in the U.S. from scratch is expensive and can take several years. Even then, having a factory in the U.S. does not necessarily protect a drug manufacturer from Trumpβs tariffs, especially if the tariffs apply to imported ingredients used in the drugs. Jacob Jensen, a trade policy analyst at the right-leaning American Action Forum, notes that
"97% of antibiotics, 92% of antiviral drugs, and 83% of the most popular generics contain at least one active ingredient manufactured overseas.β#Trump #tariffs #bigpharma #drugs #pharmaceuticals Don't miss it, subscribe to π± Old Glory Vortex πΊπΈ
Available now! Telegram Research 2025 β the year's key insights 
